Genomic DNA Concatenation for Mutation Detection Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Detecting somatic mutations in diseases is challenging due to errors in library preparation and sequencing methods, especially in samples with low diversity and low copy number mutations, making it difficult to distinguish genuine mutations from artifacts.

Innovation Solution

A method involving concatenating genomic DNA fragments, sequencing the concatenated DNA, and grouping sequence reads by 3′ and 5′ end sequences and flanking sequences to determine the genuineness of sequence variations using the number of reads and groups containing the variation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If next generation sequencing is used to detect somatic mutations, then sequencing throughput and coverage are improved, but the ability to distinguish genuine mutations from errors deteriorates due to PCR and sequencing errors

Engineering Contradiction:
Improvesequencing throughputVSAvoidmutation detection accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The method segments the detection problem by analyzing individual molecular clones separately rather than pooling all reads together. Each clone is evaluated independently to determine if it contains a genuine mutation or an error, allowing high-throughput sequencing to maintain its productivity while improving measurement precision through individual clone assessment

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method performs preliminary cloning and individual clone sequencing before final mutation calling. This preliminary action of separating reads into individual clone groups allows errors to be identified and filtered out before making the final determination of genuine mutations, thereby improving accuracy without sacrificing throughput

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If samples with low diversity and low copy number mutations are analyzed, then the ability to detect rare mutations is improved, but the confidence in distinguishing genuine mutations from errors deteriorates

Engineering Contradiction:
Improverare mutation detection capabilityVSAvoidconfidence in mutation authenticity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

By segmenting the sample into individual molecular clones and analyzing each separately, the method can detect rare mutations with high precision while maintaining reliability. Each clone serves as an independent unit of analysis, allowing rare mutations to be identified with confidence based on their presence in specific clones rather than being lost in the noise of pooled sequencing data

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method creates multiple copies (clones) of individual DNA molecules and sequences each copy separately. For genuine mutations, the same variant will be observed in multiple independent clones, providing statistical confidence. For errors, the variant will typically appear in only one clone, allowing discrimination between true mutations and artifacts

Inventive Principle:
Principle #26Copying

3Device complexity

If traditional sequencing methods are used without cloning, then the process complexity is reduced, but the ability to correct systematic errors deteriorates

Engineering Contradiction:
Improvesequencing process complexityVSAvoiderror correction capability
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The method segments the sequencing process into individual clone analyses, which adds a layer of complexity but enables systematic error correction. By treating each clone separately and comparing results across multiple clones, the method can identify and correct systematic errors while maintaining reasonable process complexity through automated analysis pipelines

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS12104202B2Method of identifying sequence variants using concatenation
Publication Date: 2024.10.01 OXFORD NANOPORE TECH LTD
  • US12104202B2 patent drawing
  • US12104202B2 patent drawing

AI summary

Described herein, among other things, is a method of sequencing, comprising: concatenating a plurality of fragments of genomic DNA to produce concatenated DNA; sequencing the concatenated DNA to produce a plurality of sequence reads, wherein at least some of the sequence reads comprise: at least the sequence of the 3′ and/or 5′ ends of a fragment that corresponds to the locus of interest and sequence of one or both of the fragments that flank the fragment in the concatenated DNA; and grouping the sequence reads that corresponds to the locus of interest using, for each of the grouped sequence reads: the 3′ and/or 5′ end sequences; and/or the flanking sequence.